Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage

Jun Liao, Lazaros Kochilas, Sonja Nowotschin, Jelena S. Arnold, Vimla S. Aggarwal, Jonathan A. Epstein, M. Christian Brown, Joe Adams, Bernice E. Morrow

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is associated with de novo hemizygous 22q11.2 deletions and is characterized by malformations attributed to abnormal development of the pharyngeal arches and pouches. The main physical findings include aortic arch and outflow tract heart defects, thymus gland hypoplasia or aplasia and craniofacial anomalies. The disorder varies greatly in expressivity; while some patients are mildly affected with learning disabilities and subtle craniofacial malformations, others die soon after birth with major cardiovascular defects and thymus gland aplasia. In addition to the main clinical features, many other findings are associated with the disorder such as chronic otitis media and hypocalcemia. Tbx1, a gene encoding a T-box transcription factor, which is hemizygously deleted on chromosome 22q11.2, was found to be a strong candidate for the equivalent of human VCFS/DGS in mice. Mice hemizygous for a null allele of Tbx1 had mild malformations, while homozygotes had severe malformations in the affected structures; neither precisely modeling the syndrome. Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients. By employing genetic complementation studies, we demonstrate that altered TBX1 dosage and not overexpression of the other transgenes is responsible for most of the defects in the BAC transgenic mice. Furthermore, the full spectrum of VCFS/DGS malformations was elicited in a Tbx1 dose dependent manner, thus providing a molecular basis for the pathogenesis and varied expressivity of the syndrome.

Original languageEnglish (US)
Pages (from-to)1577-1585
Number of pages9
JournalHuman Molecular Genetics
Volume13
Issue number15
DOIs
StatePublished - Aug 1 2004

Fingerprint

DiGeorge Syndrome
Bacterial Artificial Chromosomes
Transgenes
Thymus Gland
Transgenic Mice
Branchial Region
Hypocalcemia
Learning Disorders
Homozygote
Otitis Media
Thoracic Aorta
Transcription Factors
Chromosomes
Alleles
Parturition

ASJC Scopus subject areas

  • Genetics

Cite this

Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. / Liao, Jun; Kochilas, Lazaros; Nowotschin, Sonja; Arnold, Jelena S.; Aggarwal, Vimla S.; Epstein, Jonathan A.; Brown, M. Christian; Adams, Joe; Morrow, Bernice E.

In: Human Molecular Genetics, Vol. 13, No. 15, 01.08.2004, p. 1577-1585.

Research output: Contribution to journalArticle

Liao, J, Kochilas, L, Nowotschin, S, Arnold, JS, Aggarwal, VS, Epstein, JA, Brown, MC, Adams, J & Morrow, BE 2004, 'Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage', Human Molecular Genetics, vol. 13, no. 15, pp. 1577-1585. https://doi.org/10.1093/hmg/ddh176
Liao, Jun ; Kochilas, Lazaros ; Nowotschin, Sonja ; Arnold, Jelena S. ; Aggarwal, Vimla S. ; Epstein, Jonathan A. ; Brown, M. Christian ; Adams, Joe ; Morrow, Bernice E. / Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. In: Human Molecular Genetics. 2004 ; Vol. 13, No. 15. pp. 1577-1585.
@article{a14cc6cf3d0c432693fdbe7b726a2a5d,
title = "Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage",
abstract = "Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is associated with de novo hemizygous 22q11.2 deletions and is characterized by malformations attributed to abnormal development of the pharyngeal arches and pouches. The main physical findings include aortic arch and outflow tract heart defects, thymus gland hypoplasia or aplasia and craniofacial anomalies. The disorder varies greatly in expressivity; while some patients are mildly affected with learning disabilities and subtle craniofacial malformations, others die soon after birth with major cardiovascular defects and thymus gland aplasia. In addition to the main clinical features, many other findings are associated with the disorder such as chronic otitis media and hypocalcemia. Tbx1, a gene encoding a T-box transcription factor, which is hemizygously deleted on chromosome 22q11.2, was found to be a strong candidate for the equivalent of human VCFS/DGS in mice. Mice hemizygous for a null allele of Tbx1 had mild malformations, while homozygotes had severe malformations in the affected structures; neither precisely modeling the syndrome. Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients. By employing genetic complementation studies, we demonstrate that altered TBX1 dosage and not overexpression of the other transgenes is responsible for most of the defects in the BAC transgenic mice. Furthermore, the full spectrum of VCFS/DGS malformations was elicited in a Tbx1 dose dependent manner, thus providing a molecular basis for the pathogenesis and varied expressivity of the syndrome.",
author = "Jun Liao and Lazaros Kochilas and Sonja Nowotschin and Arnold, {Jelena S.} and Aggarwal, {Vimla S.} and Epstein, {Jonathan A.} and Brown, {M. Christian} and Joe Adams and Morrow, {Bernice E.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1093/hmg/ddh176",
language = "English (US)",
volume = "13",
pages = "1577--1585",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage

AU - Liao, Jun

AU - Kochilas, Lazaros

AU - Nowotschin, Sonja

AU - Arnold, Jelena S.

AU - Aggarwal, Vimla S.

AU - Epstein, Jonathan A.

AU - Brown, M. Christian

AU - Adams, Joe

AU - Morrow, Bernice E.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is associated with de novo hemizygous 22q11.2 deletions and is characterized by malformations attributed to abnormal development of the pharyngeal arches and pouches. The main physical findings include aortic arch and outflow tract heart defects, thymus gland hypoplasia or aplasia and craniofacial anomalies. The disorder varies greatly in expressivity; while some patients are mildly affected with learning disabilities and subtle craniofacial malformations, others die soon after birth with major cardiovascular defects and thymus gland aplasia. In addition to the main clinical features, many other findings are associated with the disorder such as chronic otitis media and hypocalcemia. Tbx1, a gene encoding a T-box transcription factor, which is hemizygously deleted on chromosome 22q11.2, was found to be a strong candidate for the equivalent of human VCFS/DGS in mice. Mice hemizygous for a null allele of Tbx1 had mild malformations, while homozygotes had severe malformations in the affected structures; neither precisely modeling the syndrome. Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients. By employing genetic complementation studies, we demonstrate that altered TBX1 dosage and not overexpression of the other transgenes is responsible for most of the defects in the BAC transgenic mice. Furthermore, the full spectrum of VCFS/DGS malformations was elicited in a Tbx1 dose dependent manner, thus providing a molecular basis for the pathogenesis and varied expressivity of the syndrome.

AB - Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is associated with de novo hemizygous 22q11.2 deletions and is characterized by malformations attributed to abnormal development of the pharyngeal arches and pouches. The main physical findings include aortic arch and outflow tract heart defects, thymus gland hypoplasia or aplasia and craniofacial anomalies. The disorder varies greatly in expressivity; while some patients are mildly affected with learning disabilities and subtle craniofacial malformations, others die soon after birth with major cardiovascular defects and thymus gland aplasia. In addition to the main clinical features, many other findings are associated with the disorder such as chronic otitis media and hypocalcemia. Tbx1, a gene encoding a T-box transcription factor, which is hemizygously deleted on chromosome 22q11.2, was found to be a strong candidate for the equivalent of human VCFS/DGS in mice. Mice hemizygous for a null allele of Tbx1 had mild malformations, while homozygotes had severe malformations in the affected structures; neither precisely modeling the syndrome. Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients. By employing genetic complementation studies, we demonstrate that altered TBX1 dosage and not overexpression of the other transgenes is responsible for most of the defects in the BAC transgenic mice. Furthermore, the full spectrum of VCFS/DGS malformations was elicited in a Tbx1 dose dependent manner, thus providing a molecular basis for the pathogenesis and varied expressivity of the syndrome.

UR - http://www.scopus.com/inward/record.url?scp=4344645793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344645793&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddh176

DO - 10.1093/hmg/ddh176

M3 - Article

C2 - 15190012

AN - SCOPUS:4344645793

VL - 13

SP - 1577

EP - 1585

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 15

ER -